Fundraising FoxMPM BioImpact — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
Clinicalink offers a digital tool designed to improve drug adherence and measure the functional quality of weight loss.
Digital HealthHealthtechSaaSWinston-Salem, US
Douglas E. Pierce, Jr.(Executive Officer, Director, Promoter)Joe Schmidt(Executive Officer)Edward S. Seguine(Executive Officer, Director, Promoter)
BoardMatt King(Director)inBrad Geesaman(Director)
Board seatTony RosenbergTodd FoleyAnsbert Gadicke· per SEC Form D
Co-investorsFCA Venture PartnersMcKesson Ventures
Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.
BiotechCambridge, US
Robert Millman(Executive Officer, Director)
BoardTodd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)
Co-investorsARCH Venture PartnersF-Prime CapitalJDRF T1D FundORI CapitalSlater Technology Fund6 Dimensions Capital+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.